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compared to that of HepG2 or SNU475 with the GA or AA
genotype.
Conclusions: Our ﬁndings suggested that the EGF 61AA
genotype may lower HCC risk compared with GG and GA
genotypes, and have lower level of EGF protein. In addition,
block EGF signaling transduction via geﬁtinib can slowdown
the proliferations of some HCC cell lines.
I-29 The natural history of infections caused by
varicella-zoster virus (VZV): primary infection,
transmission, latency, and reactivation.
M.D. Gershon*. Department of Pathology & Cell Biology,
Columbia University College of Physicians and Surgeons,
New York, USA
Studies of live attenuated varicella vaccine (Oka strain)
have led to increased understanding of the behavior of this
virus in human populations. For example, it has become
clear that VZV spreads predominately from the skin lesions
of patients with varicella (chickenpox) or zoster (shingles),
which contain high concentrations of cell-free virions that
are highly transmissible to others by the airborne route. At
least 3 cellular receptors for VZV have been identiﬁed.
This presentation will focus on the importance of the
mannose 6-phosphate receptor (MPR) and its role in viral
entry and egress from cells. Because MPRs are lost during
the natural maturation of the superﬁcial epidermis, VZV-
infected maturing keratinocytes release infectious viral
particles into the epidermal vesicles that form during
varicella or zoster. In human infection, cellular immunity
is required for host defense against VZV because non-
epidermal cells express MPRs and thus do not release
infectious virions. VZV thus spreads from one cell to another
without entering the extracellular space. The exclusive
cell-to-cell spread of VZV in the body contributes to the
relatively long varicella incubation period, decreases the
viral load during disease (because much of the intracellular
virus is degraded in endosomes), and prevents the host
from being overwhelmed by VZV. In evolutionary terms, it
is an advantage for the virus not to overwhelm its host
and to establish a latent infection so that it can persist
after a varicella epidemic has exhausted the population of
susceptible hosts, and reactivate to spread again, after a
population of susceptible hosts is regenerated.
In an in vitro neuronal model of VZV infection, only cell-free
VZV establishes latent infection. Because the epidermis is
the only site in which infectious free virions emerge, this
observation suggests that skin infection is necessary for the
establishment of VZV latency. Infection of intraepidermal
sensory nerve terminals enables VZV to establish latency
in dorsal root and cranial nerve ganglia. During latency, a
limited number of VZV genes are transcribed. The same
genes are transcribed during latency in infected human
ganglia and in cultured intestinal neurons isolated from
either guinea pig or mouse. This neuronal model of VZV
infection is useful because lytic or latent infections can
be studied and VZV can be reactivated from latency. Both
wild-type VZV and the vaccine (Oka) strain can establish
latency and reactivate in neurons in vitro.
Basic studies on VZV have helped to promote understanding
of how varicella vaccine behaves in human hosts. This
knowledge, in turn, has contributed to recommendations
for vaccine use. For example, the risk of manifesting zoster
is low in vaccinees who lack a history of skin lesions from
either vaccine or wild type VZV. In addition, skin lesions with
infectious VZV are required for host-to-host transmission;
therefore, decreasing the number of skin lesions due to VZV
decreases VZV transmission. In order to maximize protection
of vaccinees from chickenpox and minimize skin lesions, two
doses of vaccine are now recommended for all children in
the United States.
Concurrent Session 5 Usage of Antibiotics and
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I-30 Antibiotics application in China
Y.H. Xiao*. Institute of Clinical Pharmacology, Peking
University, Beijing, 100083, China
Antimicrobial agents is the most frequent prescribed
drug in China, near 40% of the drug consumption is
antimicrobial agents, 60 70% of hospitalized patients
receive antimicrobial agent therapy and 20 30% outpatient
prescriptions contain those agents. The top three
antimicrobials by the drug classiﬁcation are ﬂuoroquinolone,
cephalosporin and macrolide. The irrational antibiotic
application is a severe public health problem in China.
In community and hospital setting, antimicrobials
are used for the treatment of bacterial infection,
common cold and other un-infectives. The catalog of
antimicrobials irrational use reasons includes prescription
without indication, favoring intravenous administration,
unnecessary combination, longer duration, higher dosage
and others.
Except healthcare consumption, half of the antibiotic
output is used in animal breeding as growth promoter,
which is added in the animal feeding.
The reasons of irrational use are: healthcare system
ﬁnancial compensation defect, patient claim and pressure,
unmet physician education, STG unavailable and industrial
promotion.
The results of irrational use of antimicrobials are:
1. Severe bacterial resistance: 70% E. coli being
resistant to ﬂuoroquinolone, over 80% macrolide-
resistant Streptococcus and Staphylococcus being
detected, ESBLs(+) Enterobacteriaceae being 10 20%,
penicillin non-sensitive S. pneumoniae increasing
steadily, methicillin-resistant Staphylococcus being 60%
national-widely, etc.
2. Antibiotic-related ADR and drug sufferings: 50% ADR
report collected in national ADR center was antibiotic-
related, some national wide drug sufferings was reported
occasionally.
3. Wasting medicinal resource.
The measures ﬁghting against the antibiotic irrational use
should be:
1. Healthcare system reform, which is being on the way.
2. STG generating and enforcing; some hospitals or medical
associations are preparing their own STG.
3. Professional employees and patients education.
4. Legalization industrial promotion.
5. Restriction of animal use for growth promoter.
I-31 Prenyltransferases as targets for antibiotic drug
discovery
A.H.J. Wang*. Institute of Biological Chemistry, Academia
Sinica, Taipei 11529, Taiwan
Prenyltransferases are involved in many biological
pathways; thus they are useful for developing new drugs
for various diseases. We have studied by structural analysis
the product chain length determinants of several trans-type
prenyltransferases, including geranylgeranyl pyrophosphate
synthase (GGPPS) and so on. The speciﬁcities were
determined by the size and depth of the activity site
cavity. Large amino acids form the ﬂoor to block product
further elongation. In addition, we solved the structures
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of yeast GGPPS complexed with several bisphosphonate
inhibitors. Undecaprenyl diphosphate synthase (UPPS), a cis-
prenyltransferase, produces C55-undecaprenyl diphosphate
(UPP) via cis double-bond addition. UPP is used for
peptidoglycan cell-wall biosynthesis in bacteria. Here,
bisphosphonates were tested as inhibitors of UPPS. In the
UPPS-inhibitor complexes, four distinct binding sites were
observed. The availability of these structures opens up
new avenues for the design of novel inhibitors. Finally,
dehydrosqualene synthase (CrtM) from Staphylococcus
aureus, uses the head-to-head condensation of two
molecules of farnesyl diphosphate (FPP) to produce the
presqualene diphosphate C30 molecule, the precursor for
of staphyloxanthin, the golden carotenoid pigment which
promotes bacterial resistance to reactive oxygen species
and host neutrophil-based killing. CrtM, therefore, has been
tested as the target to treat infections by methicillin-
resistant S. aureus (MRSA). We found squalene synthase
inhibitors for cholesterol-lowering activity in humans bind to
CrtM and block the biosynthesis of staphyloxanthin in vitro,
resulting in colorless bacteria with increased susceptibility
to killing by human blood and to innate immune clearance
in a mouse infection model.
I-32 Antibiotic use and epidemiology characteristic of
methicillin-resistant Staphylococcus aureus in
Chinese pediatrics
X.Z. Shen1 *, W.S. Zhang1, H. Zhang2, C.Q. Wang3,
J.H. Zhen1, Q.L. Deng4, L. Liu5, X.H. Wang3, K.H. Yao1,
S.J. Yu1, Y.H. Yang1. 1Beijing Children’s Hospital afﬁliated
to Capital Medical University, Beijing, China, 2Shanghai
Children’s Hospital afﬁliated to Shanghai Jiaotong
University, Shanghai, China, 3Children’s Hospital afﬁliated
to Fudan University, Shanghai, China, 4Guangzhou
Children’s Hospital afﬁliated to Guangzhou Medical
College, Guangzhou, China, 5Chongqing Children’s Hospital
afﬁliated to Chongqing Medical University, Chongqing,
China
The global escalation in both community- and hospital-
acquired antimicrobial-resistant bacteria is threatening the
ability to effectively treat patients, but there is not enough
concern about the antibiotic rational use. Now the antibiotic
irrational use and the development of antibiotic resistance
have already been a problem threatening public health.
This survey included the 5 main children’s hospitals in the 4
biggest cities in China, All hospitalized patients aged 0 15
years were included from 2002 to 2005. We have evaluated
the use of the systemic antibacterial drugs (ATC-group
J01) using the ATC/DDD methodology. Data were expressed
as the number of DDD per 100 bed-days of inpatients.
The Drug Utilization 90% (DU90%), were determined. The
overall inpatient use of antibiotic drugs was 68.2, 58.4,
65.8, 65.6 and 49.9 DDD/100 bed-days for the years 2002
to 2006, respectively. Beta-lactam antibacterials were the
most used subgroups and the top antibiotics used were
third-generation cephalosporins of inpatients. The number
of antimicrobial agents and non-restricted antibiotics within
DU90% segment ranged from 11 to 20 and from ﬁve to nine,
respectively. Antibiotics that could be injected were used
widely in admitted patients and accounted for 59.0%-99.8%.
The antibiotic overuse in inpatients was found in this study.
It could be the result of the increasing of antimicrobial-
resistant pathogens.
The emergence and dissemination of methicillin-resistant
S. aureus (MRSA) is increasing in prevalence in all regions
of Canada, in the United States, and globally. But now, the
effect of large-scale expanded surveillance for methicillin-
resistant Staphylococcus aureus (MRSA) on health care-
associated MRSA disease is not known in China. Within
the previous two decades, MRSA had been established as
a major nosocomial pathogen. In the 1980s, community-
associated MRSA (CA-MRSA) infections appeared and their
prevalence increased gradually. To investigate the genetic
differentiation and pathogenicity of MRSA from Chinese
pediatric, seventy-three MRSA isolates were analyzed by
a combination of different genotyping methods, including
multilocus sequence typing (MLST), SCC mec and spa typing.
Panton-Valentine Leukocin (PVL) gene was also detected.
The prevalent strains were ST239-MRSA-III and ST1-MRSA
clones in the northern region; ST239-MRSA-III, ST910-MRSA-
IV and ST88-MRSA in the eastern region; and ST59-MRSA
in the southern region. We also found several novel
genetic types. Antimicrobial susceptibility tests showed high
resistance of many antimicrobials and multiple drugs. PVL
gene-positive MRSA was likely to be associated with the
necrotic process in clinical infections.
I-33 Molecular identiﬁcation and typing of
methicillin-resistant Staphylococcus aureus
(MRSA)
M. Ip*. The Chinese University of Hong Kong, Prince of
Wales Hospital, Hong Kong, China
Methicillin-resistant Staphylococcus aureus (MRSA) is a
signiﬁcant cause of healthcare- and community-associated
infections. MRSA infections are a major public health
concern and its prevalence is increasing globally. Strategies
of active surveillance, aggressive patient management,
including rigorous infection prevention measures, both in
hospital setting and in the community, are necessary in the
control of MRSA infections.
Effective strategies in the control of MRSA have been
facilitated by the availability of rapid molecular diagnostic
methods for the detection and identiﬁcation of MRSA from
MRSA-infected patients and carriers. Successful infection
control programs require understanding and reducing
transmission of different strain types of MRSA. Hospital
and community genotypes of MRSA are often distinct
and need to be distinguished in establishing strategies
for control. There are pros and cons to the molecular
methods available for characterizing these MRSA strains.
Methods that are commonly used include pulsed-ﬁeld gel
electrophoresis, multilocus sequence typing (MLST), spa-
typing, and detection of staphylococcal mec cassette genes
(SCCmec) and virulence gene targets, such as panton-
valentine leukocidin (pvl) gene and other toxin genes.
Current molecular methods of detection and genotyping
of MRSA strains will be discussed.
The cost-effectiveness and clinical efﬁcacy of implementing
these technologies depends on the level of clinical service
that is available in individual hospitals and requires risk
assessments for the control of MRSA in different settings.
I-34 Resistance in S. aureus: Should epidemiology
patterns inﬂuence the choice of therapy?
H. Wang*. Peking Union Medical College Hospital, 100730,
Beijing, China
Staphylococcus aureus, which causes a wide range of clinical
infections, is a prominent pathogen in both the hospital
and the community settings. The incidence of methicillin-
resistant S. aureus (MRSA) has been increasing at an
alarming rate in Asia, along with that heterointermediate
resistance to vancomycin (hVISA). Previous data indicated
that Asia-Paciﬁc had one of the highest prevalence rates
of hospital-acquired MRSA (HA-MRSA) that ranged from
50 80%. The prevalence of HA-MRSA in Mainland China
was only 27.8% in 1999, however, in 2005, the prevalence
reached to 50.3%. The genotypic characteristics of HA-
